Madrigal Pharmaceuticals (MDGL) Change in Receivables (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Change in Receivables of $52.9 million for Q1 2026, up 595.24% year-over-year from $7.6 million in Q1 2025, and up 149.54% quarter-over-quarter from $21.2 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Change in Receivables (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 6 years of Change in Receivables data on file, last reported at $52.9 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $52.9 million, up 595.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.9 million (up 105.0% YoY), and the FY2025 annual result was $80.7 million, up 49.85% from the prior year.
- Change in Receivables improved to $52.9 million in Q1 2026 per MDGL's latest filing, from $21.2 million in the prior quarter.
- Over five years, Change in Receivables peaked at $52.9 million in Q1 2026 and troughed at $6.9 million in Q2 2024.
- A 3-year average of $23.4 million and a median of $22.3 million in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2025 and 2026: Change in Receivables decreased 9.28% in 2025, then surged 595.24% in 2026.
- A 3-year view of Change in Receivables shows it stood at $23.4 million in 2024, then dropped by 9.28% to $21.2 million in 2025, then surged by 149.54% to $52.9 million in 2026.
- Business Quant data shows MDGL's Change in Receivables at $52.9 million in Q1 2026, $21.2 million in Q4 2025, and $34.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | 52.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.88 Mn |
| Mar 31, 2026 | 52.88 Mn |
| Dec 31, 2025 | 21.19 Mn |
| Dec 31, 2025 | 21.19 Mn |
| Sep 30, 2025 | 34.05 Mn |
| Sep 30, 2025 | 34.05 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Mar 31, 2025 | 7.61 Mn |
| Mar 31, 2025 | 7.61 Mn |
| Dec 31, 2024 | 23.36 Mn |
| Dec 31, 2024 | 23.36 Mn |
| Sep 30, 2024 | 23.56 Mn |
| Sep 30, 2024 | 23.56 Mn |
| Jun 30, 2024 | 6.90 Mn |
| Jun 30, 2024 | 6.90 Mn |
| Mar 31, 2016 | -7,000.00 |
| Mar 31, 2016 | -7,000.00 |
| Mar 31, 2011 | -116,000.00 |
| Mar 31, 2011 | -116,000.00 |